Purchase Order 36C25726P0170
- Not listed
- This is a $215,099 firm-fixed-price purchase order awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 4 (VISN 4). The contract is for the delivery of the radiopharmaceutical drug XOFIGO (radium-223 dichloride) through June 2025. Cardinal Health 414 is a major supplier of radiopharmaceuticals and specialized pharmaceutical products to federal healthcare agencies like the VA, Department of...
- This federal contract award, valued at $261,303.00, was issued by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC for the supply of the radiopharmaceutical product Xofigo (radium-223 dichloride). The contract is a firm fixed-price purchase order with an ultimate completion date of April 11, 2026. Cardinal Health 414, LLC is a subsidiary of the larger Cardinal Health, Inc., a global healthcare services company that...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of the radiopharmaceutical Xofigo (radium-223 dichloride) for prostate cancer treatment. The contract has a ceiling value of $170,415.00 and a period of performance through June 28, 2026. Cardinal Health 414, LLC is a major supplier of...
- This is a $31,018.03 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC for the emergency supply of the radiopharmaceutical Xofigo (radium-223 dichloride) for prostate cancer treatment. Cardinal Health 414 is a subsidiary of the global healthcare services company Cardinal Health, Inc. and specializes in providing radiopharmaceuticals and related products to federal agencies, including the VA, Department of Defense, and National...
- This federal contract award is for the delivery of the radiopharmaceutical product XOFIGO (radium-223 dichloride) to the U.S. Department of Veterans Affairs (VA). The $283,002.51 firm fixed-price delivery order was awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a global healthcare services company specializing in the distribution of pharmaceuticals and medical products. The contract has an ultimate completion date of September 30, 2026. Cardinal Health 414, LLC is...
- This federal contract award is for the delivery of RADIUM 223 XOFIGO, a radiopharmaceutical product, to the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 17. The contract was awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a global healthcare services company. The contract has a potential value of $382,864.08 and is a firm fixed price delivery order with no set-aside designation. Cardinal Health 414 has provided...
- This firm fixed-price purchase order contract was awarded by the Veterans Integrated Service Network 4 (VISN 4), a division of the U.S. Department of Veterans Affairs (VA), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract has a ceiling value of $64,325.92 and is for the delivery of the radiopharmaceutical Xofigo (radium-223 dichloride) to support nuclear medicine and oncology services for the VA healthcare system. The contract has an ultimate completion date of...
- This federal contract award to Cardinal Health 414, LLC was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration. The $270,000.00 firm fixed price delivery order is for the radiopharmaceutical product Xofigo Radium 223. The contract has a completion date of February 1, 2019. Cardinal Health 414 is a subsidiary of the global healthcare services company Cardinal Health, Inc. and has previously delivered radiopharmaceuticals, diagnostic imaging agents, and other...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a $15,863.85 firm-fixed-price purchase order to Cardinal Health 414, LLC for the delivery of an emergency dose of the radiopharmaceutical Xofigo. Cardinal Health 414, LLC is a subsidiary of the global healthcare company Cardinal Health, Inc. that specializes in providing radiopharmaceuticals and other medical products to federal agencies such as the VA, Department of Defense, and...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $109,948.16 firm fixed price contract is for the delivery of the radiopharmaceutical product Xofigo Radium Ra 223 Dichloride. The contract, which has a completion date of March 31, 2021, was not set aside for any specific business type. Cardinal Health 414 holds several indefinite delivery vehicles (IDVs) to provide...
Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., has been awarded a firm fixed-price purchase order valued at $74,962.90 for XOFIGO (radium-223 dichloride), a specialized radiopharmaceutical used in oncology treatment. The contract was awarded on January 9, 2026, with an ultimate completion date of July 31, 2026, and carries no set-aside designation, indicating full and open competition. The award was issued by Veterans Integrated Service Network 17 (VISN 17), the civilian funding agency within the Department of Veterans Affairs, with performance to occur at Cardinal Health 414's facility in Dublin, Ohio. Cardinal Health 414, LLC specializes in supplying critical radiopharmaceuticals and medical isotopes to federal healthcare agencies, particularly the VA and its various Veterans Integrated Service Networks. The company maintains an extensive portfolio of Indefinite Delivery Vehicle (IDV) contracts across multiple VISNs and other federal healthcare agencies, positioning it as a key supplier of nuclear medicine and oncology products to VA medical centers and military treatment facilities. This purchase order represents a specific delivery against the company's broader contracting relationship with the VA healthcare system for specialized radiopharmaceutical therapies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $75.0k | 1/9/26 |